FR2448901A1 - Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle - Google Patents

Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle

Info

Publication number
FR2448901A1
FR2448901A1 FR8002166A FR8002166A FR2448901A1 FR 2448901 A1 FR2448901 A1 FR 2448901A1 FR 8002166 A FR8002166 A FR 8002166A FR 8002166 A FR8002166 A FR 8002166A FR 2448901 A1 FR2448901 A1 FR 2448901A1
Authority
FR
France
Prior art keywords
glue
fibrinogen
factor xiii
animals
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8002166A
Other languages
English (en)
French (fr)
Other versions
FR2448901B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Immuno AG fuer Chemisch Medizinische Produkte
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3508554&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2448901(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno AG, Immuno AG fuer Chemisch Medizinische Produkte filed Critical Immuno AG
Publication of FR2448901A1 publication Critical patent/FR2448901A1/fr
Application granted granted Critical
Publication of FR2448901B1 publication Critical patent/FR2448901B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8002166A 1979-02-15 1980-01-31 Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle Granted FR2448901A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT119079A AT359653B (de) 1979-02-15 1979-02-15 Verfahren zur herstellung eines gewebekleb- stoffes

Publications (2)

Publication Number Publication Date
FR2448901A1 true FR2448901A1 (fr) 1980-09-12
FR2448901B1 FR2448901B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-07

Family

ID=3508554

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8002166A Granted FR2448901A1 (fr) 1979-02-15 1980-01-31 Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle

Country Status (15)

Country Link
US (2) US4298598A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS55110557A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (2) AR226837A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT359653B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE881467A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1119516A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH649925A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3002933C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK151611B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES8101382A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2448901A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2042556B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1141212B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL190748B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE453800B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253198A1 (de) * 1986-07-05 1988-01-20 BEHRINGWERKE Aktiengesellschaft Einkomponenten-Gewebekleber sowie Verfahren zu seiner Herstellung
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US7078232B2 (en) 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
WO2011061705A1 (fr) 2009-11-18 2011-05-26 Lfb Biomedicaments Procede de traitement du plasma sanguin comprenant une etape de lavage par dispersion
US8383104B2 (en) 2005-12-16 2013-02-26 Laboratoire Francais Du Fractionnement Et Des Biotechnologies S.A. Thrombin-free biological adhesive and use thereof as a medicament
US8598319B2 (en) 2005-06-29 2013-12-03 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins

Families Citing this family (169)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4287777A (en) * 1976-09-13 1981-09-08 Bunker Ramo Corporation Semi-automatic contact insertion tool
ATE20824T1 (de) 1981-06-25 1986-08-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung.
DE3175003D1 (en) 1981-06-25 1986-08-28 Serapharm Gmbh & Co Kg Enriched plasma derivative for promoting wound sealing and wound healing
US4442655A (en) * 1981-06-25 1984-04-17 Serapharm Michael Stroetmann Fibrinogen-containing dry preparation, manufacture and use thereof
AT369990B (de) * 1981-07-28 1983-02-25 Immuno Ag Verfahren zur herstellung eines gewebeklebstoffes
DE3203775A1 (de) * 1982-02-04 1983-08-11 Behringwerke Ag, 3550 Marburg Fibrinogenzubereitung, verfahen zu ihrer herstellungund ihre verwendung
JP2648301B2 (ja) * 1983-12-27 1997-08-27 ジエネテイツクス・インスチチユ−ト・インコ−ポレ−テツド 真核細胞の形質転換のための補助ｄｎａを含むベクター
US4600574A (en) * 1984-03-21 1986-07-15 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Method of producing a tissue adhesive
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.
US5112805A (en) * 1985-11-22 1992-05-12 Labsystems, Oy Pharmaceutical preparation for promoting epithelial healing and prevention of epithelial destruction
US5180583A (en) * 1985-11-26 1993-01-19 Hedner Ulla K E Method for the treatment of bleeding disorders
KR870005646A (ko) * 1985-12-16 1987-07-06 로버트 엘. 미니어 수술후 유착형성 억제방법
US4889722A (en) * 1985-12-16 1989-12-26 Ethicon, Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
FR2618784B1 (fr) * 1987-07-30 1990-04-06 Lille Transfusion Sanguine Concentre de proteines coagulables par la thrombine, son procede d'obtention et son utilisation a titre de colle biologique
US5260420A (en) * 1987-07-30 1993-11-09 Centre Regional De Transfusion Sanguine De Lille Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
JP2526073B2 (ja) * 1987-10-06 1996-08-21 株式会社ミドリ十字 異常破水治療剤
JP2678193B2 (ja) * 1988-03-31 1997-11-17 財団法人化学及血清療法研究所 ヒト血漿由来血液凝固第ｘ▲ｉｉｉ▼因子の製造方法
AT397203B (de) * 1988-05-31 1994-02-25 Immuno Ag Gewebeklebstoff
US4837379A (en) * 1988-06-02 1989-06-06 Organogenesis Inc. Fibrin-collagen tissue equivalents and methods for preparation thereof
US4973466A (en) * 1988-06-21 1990-11-27 Chiron Ophthalmics, Inc. Wound-healing dressings and methods
US5226877A (en) * 1989-06-23 1993-07-13 Epstein Gordon H Method and apparatus for preparing fibrinogen adhesive from whole blood
JPH05501814A (ja) * 1989-08-10 1993-04-08 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 組織接着剤成分の医療用送り出しシステム
US5599558A (en) * 1989-09-15 1997-02-04 Curative Technologies, Inc. Selecting amounts of platelet releasate for efficacious treatment of tissue
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5030215A (en) * 1990-01-03 1991-07-09 Cryolife, Inc. Preparation of fibrinogen/factor XIII precipitate
US5292362A (en) * 1990-07-27 1994-03-08 The Trustees Of Columbia University In The City Of New York Tissue bonding and sealing composition and method of using the same
US5420250A (en) * 1990-08-06 1995-05-30 Fibrin Corporation Phase transfer process for producing native plasma protein concentrates
US5644032A (en) * 1990-08-06 1997-07-01 Fibrin Corporation Process for producing fibrinogen concentrates
AU667188B2 (en) * 1990-11-27 1996-03-14 American National Red Cross, The Tissue sealant and growth factor containing compositions that promote accelerated wound healing
US6559119B1 (en) 1990-11-27 2003-05-06 Loyola University Of Chicago Method of preparing a tissue sealant-treated biomedical material
US6117425A (en) * 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6197325B1 (en) * 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7189410B1 (en) 1990-11-27 2007-03-13 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
AU1461592A (en) * 1991-02-07 1992-09-07 Fibratek, Inc. Fibrinogen based adhesive
US6613324B1 (en) * 1991-02-28 2003-09-02 Bristol-Myers Squibb Company Adhesive for the gluing of biological tissues
DK83092D0 (da) * 1992-06-24 1992-06-24 Unes As Fremgangsmaade til udvinding af thrombin
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
ES2182840T3 (es) * 1993-03-30 2003-03-16 Hoechst Japan Factor xiii para el tratamiento de heridas de la piel.
US5795780A (en) * 1993-06-23 1998-08-18 Bristol-Myers Squibb Company Method of use of autologous thrombin blood fraction in a cell culture with keratinocytes
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
US5583114A (en) 1994-07-27 1996-12-10 Minnesota Mining And Manufacturing Company Adhesive sealant composition
USRE38827E1 (en) 1994-07-27 2005-10-11 3M Innovative Properties Company Adhesive sealant composition
US5585007A (en) 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
JPH11507277A (ja) * 1995-06-07 1999-06-29 ジ・アメリカン・ナショナル・レッド・クロス 補足された及び補足されていない組織シーラント、その製造法及び使用法
DE19521324C1 (de) * 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
US5948427A (en) * 1996-04-25 1999-09-07 Point Medical Corporation Microparticulate surgical adhesive
WO2000062828A1 (en) 1996-04-30 2000-10-26 Medtronic, Inc. Autologous fibrin sealant and method for making the same
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
GB2318732A (en) * 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
US5844087A (en) * 1996-11-05 1998-12-01 Bayer Corporation Method and device for delivering fibrin glue
US6121232A (en) * 1997-01-31 2000-09-19 Omrix Biopharmaceuticals Sa Stabilized mixture comprising fibrinogen
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
AT406120B (de) 1997-08-28 2000-02-25 Immuno Ag Gewebekleber
DE19755023C2 (de) * 1997-12-11 2000-03-09 Celanese Chem Europe Gmbh Katalysator und Verfahren zur Herstellung von Vinylacetat
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6884230B1 (en) 1998-03-09 2005-04-26 Baxter International Inc. Dispensing head for a tissue sealant applicator and process of use
AU2763099A (en) 1998-06-22 2000-01-10 Charles E. Worden Enriched platelet wound healant
US6524568B2 (en) * 1998-06-22 2003-02-25 Cytomedix, Inc. Enriched platelet wound healant
US20020022588A1 (en) * 1998-06-23 2002-02-21 James Wilkie Methods and compositions for sealing tissue leaks
US6274090B1 (en) 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US6921380B1 (en) 1998-10-01 2005-07-26 Baxter International Inc. Component mixing catheter
EP1156765A4 (en) 1998-11-12 2002-08-07 Polymer Biosciences Inc A POLYMER USEFUL FOR BLOOD COagulation
AT500670A1 (de) * 1999-05-19 2006-02-15 Bio & Bio Licensing Sa Arzneimittel zur lokalen anwendung
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
US6463335B1 (en) 1999-10-04 2002-10-08 Medtronic, Inc. Temporary medical electrical lead having electrode mounting pad with biodegradable adhesive
DE60042343D1 (de) * 1999-12-23 2009-07-16 Csl Ltd Abtrennung von fibrinogen von plasmaproteasen
WO2002005898A1 (en) * 2000-07-17 2002-01-24 Haemacure Corporation Spray head for applying a multi-component mixture
US7326412B2 (en) * 2000-10-13 2008-02-05 Baxter International Inc. Fibrinogen plus a non-plasmin-acting fibrinolysis inhibitor for the reduction or prevention of adhesion formation
US6648911B1 (en) 2000-11-20 2003-11-18 Avantec Vascular Corporation Method and device for the treatment of vulnerable tissue site
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
US20030091559A1 (en) * 2001-10-03 2003-05-15 Woolverton Christopher J. Storage-stable human fibrinogen solutions
WO2003047530A2 (en) * 2001-12-04 2003-06-12 Woolverton Christopher J Storage-stable fibrin sealant
WO2003057072A2 (en) 2001-12-31 2003-07-17 Ares Laboratories, Llc Hemostatic compositions and methods for controlling bleeding
WO2003086494A1 (en) * 2002-04-05 2003-10-23 Baxter International Inc. Storage stable liquid sealer protein complex
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7374678B2 (en) 2002-05-24 2008-05-20 Biomet Biologics, Inc. Apparatus and method for separating and concentrating fluids containing multiple components
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP2298278B1 (en) 2002-06-07 2015-11-11 Dyax Corp. Prevention and reduction of blood loss and inflammatory response
DK2386310T3 (en) * 2002-08-28 2019-02-25 Dyax Corp Methods of preserving organs and tissues
CA2498212C (en) 2002-09-10 2012-07-17 American National Red Cross Multi-layered hemostatic dressing comprising thrombin and fibrinogen
US8834864B2 (en) 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) * 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
CN101010333B (zh) * 2004-08-27 2013-08-14 诺和诺德医疗保健公司 从生物材料中纯化凝血因子xⅲ多肽
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US8461302B2 (en) * 2004-11-23 2013-06-11 Zymogenetics, Inc. Purification of recombinant human factor XIII
EP2666493B1 (en) 2005-02-07 2020-09-23 Hanuman LLC Platelet rich plasma concentrate apparatus
US7708152B2 (en) 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
US20070014780A1 (en) * 2005-07-13 2007-01-18 Statseal Storage-stable human fibrinogen solutions
US20070248653A1 (en) * 2006-04-20 2007-10-25 Cochrum Kent C Hemostatic compositions and methods for controlling bleeding
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8430813B2 (en) * 2006-05-26 2013-04-30 Depuy Spine, Inc. Illuminated surgical access system including a surgical access device and integrated light emitter
MX2008014847A (es) 2006-05-31 2009-04-30 Baxter Int Metodo para crecimiento interno en la celula dirigido y regeneracion controlada de los tejidos en la cirugia espinal.
DK2046407T3 (en) 2006-08-02 2015-05-26 Khorionyx Implantable preparation that can be used especially for tissue supplementation and wound healing
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
EP2063832A4 (en) * 2006-08-04 2010-10-06 Stb Lifesaving Technologies In SOLID FIRM FOR THE TREATMENT OF WOUND FABRICS
GB0623607D0 (en) * 2006-11-27 2007-01-03 Haemostatix Ltd Tissue adhesive
US7806276B2 (en) 2007-04-12 2010-10-05 Hanuman, Llc Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
US20110034954A1 (en) * 2007-04-13 2011-02-10 Pacesetter, Inc. Sutureless reinforcement for and method of treating a myocardial infarction
WO2009020612A1 (en) 2007-08-06 2009-02-12 Stb Lifesaving Technologies, Inc. Methods and dressing for sealing internal injuries
EP2034010A1 (en) * 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
AU2008317874B2 (en) 2007-10-30 2013-12-19 Baxter Healthcare S.A. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
PL2259774T3 (pl) 2008-02-27 2013-04-30 Biomet Biologics Llc Sposoby i kompozycje dla wprowadzania antagonisty receptora interleukiny-1
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
EP2254991B1 (en) 2008-02-29 2018-08-22 Biomet Manufacturing, LLC A system and process for separating a material
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
JP5292025B2 (ja) * 2008-09-09 2013-09-18 一般財団法人化学及血清療法研究所 カルボン酸含有生体組織接着剤及びその調製方法
AU2009324297B2 (en) 2008-12-11 2013-12-05 Baxter Healthcare S.A. Preparations based on fibrinogen and sulfated polysaccharides
CA2744235A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9433700B2 (en) 2009-04-27 2016-09-06 Medibeacon Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
US9162006B2 (en) 2009-06-16 2015-10-20 Baxter International Inc. Hemostatic sponge
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
EP2477617B1 (en) * 2009-09-18 2018-01-31 Bioinspire Technologies Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
MX2012007056A (es) 2009-12-16 2012-09-28 Baxter Healthcare Sa Esponja hemostatica.
JP6037841B2 (ja) 2010-01-06 2016-12-07 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
ES2629349T3 (es) 2010-06-01 2017-08-08 Baxter International Inc Procedimiento para obtener composiciones hemostáticas secas y estables
US9084728B2 (en) 2010-06-01 2015-07-21 Baxter International Inc. Process for making dry and stable hemostatic compositions
JP6289096B2 (ja) 2010-06-01 2018-03-07 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 乾燥した安定な止血組成物を作製するためのプロセス
KR102320178B1 (ko) 2011-01-06 2021-11-02 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
US20140287044A1 (en) * 2011-03-04 2014-09-25 Rare Antibody Antigen Supply, Inc. Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen
EP4137164A1 (en) 2011-10-11 2023-02-22 Baxter International Inc. Hemostatic compositions
MX356185B (es) 2011-10-11 2018-05-17 Baxter Int Composiciones hemostaticas.
CN103889447B (zh) 2011-10-27 2015-11-25 巴克斯特国际公司 止血组合物
IN2014DN08122A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2012-03-06 2015-05-01 Ferrosan Medical Devices As
EP2825216B1 (en) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Dry haemostatic composition
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
AU2014283170B2 (en) 2013-06-21 2017-11-02 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
KR101567053B1 (ko) 2013-09-30 2015-11-09 한국원자력의학원 방사선 피폭에 의한 간 손상 예측용 바이오마커 및 그 예측방법
EP3079731B1 (en) 2013-12-11 2018-08-08 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
IL247942B (en) 2014-03-27 2022-09-01 Dyax Corp Compositions and methods for treatment of diabetic macular edema
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
CA2994447A1 (en) 2015-12-11 2017-06-15 Dyax Corp. Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
JP7395113B2 (ja) 2018-05-09 2023-12-11 フェロサン メディカル デバイシーズ エイ／エス 止血組成物を調製する方法
US20230210958A1 (en) 2021-12-30 2023-07-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422407A1 (fr) * 1978-04-12 1979-11-09 Unitika Ltd Matiere cicatrisante facilitant la cicatrisation des blessures

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2422407A1 (fr) * 1978-04-12 1979-11-09 Unitika Ltd Matiere cicatrisante facilitant la cicatrisation des blessures

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253198A1 (de) * 1986-07-05 1988-01-20 BEHRINGWERKE Aktiengesellschaft Einkomponenten-Gewebekleber sowie Verfahren zu seiner Herstellung
US6429013B1 (en) 1999-08-19 2002-08-06 Artecel Science, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US6841150B2 (en) 1999-08-19 2005-01-11 Artecal, Sciences, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US7033587B2 (en) 1999-08-19 2006-04-25 Artecel Sciences, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US7078232B2 (en) 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US8048673B2 (en) 1999-08-19 2011-11-01 Artecel Sciences, Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US8911994B2 (en) 1999-08-19 2014-12-16 Artecel Sciences Inc. Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair
US8598319B2 (en) 2005-06-29 2013-12-03 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins
EP2772499A1 (fr) 2005-06-29 2014-09-03 Laboratoire Français du Fractionnement et des Biotechnologies Separation de proteines plasmatiques
US8383104B2 (en) 2005-12-16 2013-02-26 Laboratoire Francais Du Fractionnement Et Des Biotechnologies S.A. Thrombin-free biological adhesive and use thereof as a medicament
EP3075387A1 (fr) 2005-12-16 2016-10-05 Laboratoire Français du Fractionnement et des Biotechnologies Colle biologique exempte de thrombine et son utilisation comme medicament
WO2011061705A1 (fr) 2009-11-18 2011-05-26 Lfb Biomedicaments Procede de traitement du plasma sanguin comprenant une etape de lavage par dispersion

Also Published As

Publication number Publication date
ES488431A0 (es) 1980-12-16
ATA119079A (de) 1980-04-15
FR2448901B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-09-07
CA1119516A (en) 1982-03-09
SE8000470L (sv) 1980-08-16
DE3002933A1 (de) 1980-08-28
CH649925A5 (de) 1985-06-28
GB2042556A (en) 1980-09-24
AR222209A1 (es) 1981-04-30
SE463350B (sv) 1990-11-12
NL8000936A (nl) 1980-08-19
GB2042556B (en) 1983-04-13
US4298598A (en) 1981-11-03
IT8019911A0 (it) 1980-02-14
JPS6340547B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-08-11
SE8902376D0 (sv) 1989-06-30
AT359653B (de) 1980-11-25
SE453800B (sv) 1988-03-07
BE881467A (fr) 1980-05-16
JPS55110557A (en) 1980-08-26
ES8101382A1 (es) 1980-12-16
NL190748B (nl) 1994-03-01
DE3002933C2 (de) 1984-01-26
US4377572A (en) 1983-03-22
DK151611B (da) 1987-12-21
AR226837A1 (es) 1982-08-31
IT1141212B (it) 1986-10-01
DK65680A (da) 1980-08-16

Similar Documents

Publication Publication Date Title
FR2448901A1 (fr) Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle
FR2448900A1 (fr) Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle
RU2130946C1 (ru) Способ получения биологического клея, изготовленного из концентрированных коагулирующих факторов посредством "высаливания"
US5260420A (en) Concentrate of thrombin coagulable proteins, the method of obtaining same and therapeutical use thereof
US5290918A (en) Process for the obtention of a biological adhesive made of concentrated coagulation factors by acidic precipitation
Sgouris et al. The preparation of human fibrinolysin (plasmin)
US4552760A (en) Method for stabilizing tissue plasminogen activator and a stable aqueous solution or powder containing the same
CA2437064C (en) Storage-stable, liquid fibrinogen formulation
EP0041173B2 (en) Blood-coagulation-promoting products and methods of preparing them
JP2787317B2 (ja) トロンビン凝固性蛋白質の濃縮物、その製造方法及びその治療的用途
AT408614B (de) Thrombosemittel
JPS6236502B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK167738B1 (da) Fremgangsmaade til fremstilling af en oploesning med hoej specifik rumfangsaktivitet af et protein med vaevs-plasminogenaktivator(t-pa)-aktivitet, oploesning der indeholder protein med t-pa-aktivitet, og anvendelsen af oploesningen inden for human- og veterinaermedicinen
US4837022A (en) Composition containing tissue plasminogen activator
US3234106A (en) Soluble, purified profibrinolysin and fibrinolysin and method of producing same
IE902766A1 (en) Pasteurized glue for joining human or animal tissues
RU94036434A (ru) Способ получения концентрата фибриногена
FR2664165A1 (fr) Composition pour stabiliser le plasma sanguin en cours de pasteurisation.
JPH0725696B2 (ja) プラスミノ−ゲンの安定化方法
EP0326013A3 (en) Novel proteins derived from human alpha2-plasmin inhibitor or proteins similar thereto
de Lille llllllllllllllllllllllIlllllwglllllllllIllllllllllllllllllllllllllllllll
JPS6348220A (ja) 血液凝固第９因子複合体の製造法

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
CL Concession to grant licences
CD Change of name or company name